Evidation Health helps healthcare companies quantify and prove value in the digital era of medicine. Evidation developed its Real Life Study Solution to accelerate and enhance outcomes research through direct-to-patient trials -- virtually enrolling study participants 10x faster than traditional methods and rapidly measuring the value of digital health and traditional interventions. Evidation works across the healthcare ecosystem with top pharmaceutical companies, payers, providers, and digital healthcare companies.
Date | Amount | Type | Investors | Valuation |
---|---|---|---|---|
10/11/16 | $15,000,000 | Venture |
AMV B Capital Group Fresco Capital GE Ventures Pappas Ventures | undisclosed |
04/27/17 | $10,000,000 |
B Capital Group GE Ventures Sanofi-Genzyme BioVentures | undisclosed | |
08/01/18 | $30,000,000 | Series C |
B Capital Group GE Ventures Sanofi Ventures SV Health Investors | undisclosed |